Singapore markets closed

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5125-0.0075 (-1.44%)
At close: 04:00PM EST
0.5100 -0.00 (-0.49%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 48.73M
Enterprise value 33.09M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)75.58
Price/book (mrq)7.59
Enterprise value/revenue 58.57
Enterprise value/EBITDA -0.35

Trading information

Stock price history

Beta (5Y monthly) 0.87
52-week change 3-70.00%
S&P500 52-week change 3-7.75%
52-week high 32.3400
52-week low 30.4010
50-day moving average 30.5590
200-day moving average 30.9931

Share statistics

Avg vol (3-month) 3694.07k
Avg vol (10-day) 3356.5k
Shares outstanding 593.7M
Implied shares outstanding 6N/A
Float 884.2M
% held by insiders 19.88%
% held by institutions 112.53%
Shares short (12 Jan 2023) 46.69M
Short ratio (12 Jan 2023) 410.85
Short % of float (12 Jan 2023) 47.80%
Short % of shares outstanding (12 Jan 2023) 47.14%
Shares short (prior month 14 Dec 2022) 45.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-15,239.29%

Management effectiveness

Return on assets (ttm)-93.22%
Return on equity (ttm)-308.34%

Income statement

Revenue (ttm)565k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-62.00%
Gross profit (ttm)-85k
Net income avi to common (ttm)-86.02M
Diluted EPS (ttm)-0.7200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)60.77M
Total cash per share (mrq)0.65
Total debt (mrq)38.52M
Total debt/equity (mrq)134.91
Current ratio (mrq)1.48
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-70.94M
Levered free cash flow (ttm)-35.32M